CLEARO CLARITY SMOKING,PROTECTION,ALTERNATIVE
A Revolutionary Smoking Alternative
A Revolutionary Smoking Alternative
Benda Group is committed to providing the highest quality of health care products designed to help people live healthier and longer lives.
Our researchers are creating innovative products to enhance health and wellbeing, providing supplements, herbal remedies and fillers that have been scientifically verified to be beneficial.
We provide safe and effective products that are certified by leading research organizations. Our testing protocols ensure that our products meet the highest safety standards.
Clearo is a revolutionary new product that provides smokers with a healthier alternative to traditional cigarettes. It contains a combination of eucalyptus, cove pines, and basil which helps to protect the lungs and improve lung health. By avoiding the use of nicotine and other toxic substances found in cigarettes, Clearo provides an effective way to reduce the health risks associated with smoking.
Get lung protection with revolutionary new filling material containing healthy components that support the wellbeing of the lungs and help in their rehabilitation.
Our innovative smoking liquid not only prevents damage caused by cigarette smoking, but also improves health with a long-term optimal effect.
Get the ultimate smoking alternative to replace a bad cigarette smoking habit and reduce exposure to toxins and free radicals, while also minimizing lung inflammation.
Our innovative smoking liquid has anti-aging characteristics, helping to balance the immune activity and rehabilitation of neural functions.
INFO
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis.
INFO
Formulated using time-honored medicinal herbs, this liquid is not only non-toxic to health, but can also assist smokers in reducing the harm of continued use of tobacco and nicotine-containing products. It may even help smokers quit smoking naturally by reducing their intake of nicotine and tobacco-related toxicants, which can lead to adverse health effects.
Clearo® is a patented innovative remedy aimed at effective support against different viral respiratory diseases, including new coronavirus infection SARS-CoV2 (COVID-19)
The remedy is completely organic and its composition contains unique plant extracts fortified by micronutrients. The product does not contain GMO.
Ingredients: complex of terpenoids (monoterpenes, sesquiterpenes), flavonoids, phenolic compounds from extracts of: dianthus (Caryophylli flori), eucalyptus (Eucalypti aetheroleum), pine (Pini sylvestris), basil (Folium Ocimi Sancti), and salvia (Salviae officinalis foli). Minerals: selenium, zinc. Contains ethyl alcohol.
Active ingredients: -eugenol, β-caryophyllen, -caryophyllen; 1.8-cineole; α-and β –pinene, γ- terpinene, α- terpinene, camphene, limonene, borneol, estragole (methyl chavicol), ocimene, methyleugenol; humulene, bornyl acetate, linalyl acetate, linalool, sclareol, α-terpineol; terpenoid compounds (monoterpene, sesquiterpene, iridoid), eugenol, cineole, ocimene, pinene, zinc, selenium.
Clearo® mission: Contributes to improving the symptoms associated with SARS-CoV2 (COVID-19), pneumonia, influenza, and other acute viral diseases, as follows:
Balancing of the body’s immune system and preventing immunity overreaction (a cytokine storm), with simultaneous regulation of anti-inflammatory mechanisms, which may significantly improve recovery.
Studies on Clearo® effects against pneumonia have shown significantly reduced inflammation, airway hyperresponsiveness, airway remodeling, and relief from compromised lung mechanics and oxidative stress. The research, conducted at the Institute of São Paulo, Pulmonology Division, has shown that Clearo® significantly inhibits the inflammation in the lung tissue induced by SARS-CoV2 (COVID-19). Clearo® inhibits the synthesis and secretion of proinflammatory cytokines such as IL-1β, IL-6, IL-8, and TNF-α, and stimulates the secretion of anti-inflammatory cytokines such as IL-1RA. Research has also shown that Clearo® effectively reduces fibroblasts (scar tissue cells) activation and proliferation.
Adults with body weight up to 70 kg (154 lb):First 4 days: 60 drops in the morning. 30 drops every 3 hours throughout the day. 60 drops before bedtime. Starting from day 5: 30 drops, 2 times a day.
Adults with body weight over 70 kg (154 lb):
First 4 days:
90 drops in the morning. 30 drops every 3 hours throughout the day. 90 drops before bedtime.
Starting from day 5: 30 drops, 2 times a day.
Adults with high fever and severe disease:First 4 days: 90 drops in the morning. 50 drops every 3 hours throughout the day. 90 drops before bedtime. Starting from day 5: 30 drops, 2 times a day.
Children aged 6-12 years:First 4 days: 30 drops a day. From day 5: 10 drops, 2 times a day.
As a preventive measure:Adults: 30 drops per day. Children: 10 drops per day. Duration: 3-4 weeks every 6 months.
It can be used as an effective measure for recovery from diseases of various etiologies, including those caused by SARS-CoV2.
As a measure to reduce symptoms caused by side effects following COVID-19 vaccination.
Children under six, individual intolerance, pregnancy, oncology treatment, taking of immunosuppressant drugs, allergy to the ingredients.
Individual intolerance to the ingredients.
Although your condition may improve within a short time with the use of the Clearo®, it is recommended to continue the use of the product for 10-14 days, counting from the first day and monitoring the general condition. This can lead to a better improvement of residual symptoms of the disease.
Store in a dark, dry place at a temperature between +4 C and +26°C (from 39°F to 78°F).
Acute respiratory distress syndrome (ARDS) is one of the major problems in patients suffering from COVID-19 and pneumonia. It is also the leading cause of death from COVID-19.
Used as an aid to prescribed medicines, Clearo® has shown to be potentially highly effective in conditions associated with ARDS.
The product may significantly alleviate the condition and reduce the symptoms associated with COVID-19, pneumonia, and influenza, shorten disease progression and prevent further complications.
The pharma team is actively engaged in meeting the regulatory requirements in order to register Clearo® as a medication. Due to the extraordinary demand and to ensure immediate access to the product, the decision has now been made to release Clearo® to the market under dietary supplement regulations.
Benda Group International is a global business services company that provides a range of products and services to businesses in multiple industries.
© 2023 Benda Group - All Rights Reserved.